Atea Pharmaceuticals Inc.

AI Score

0

Unlock

3.24
0.09 (2.86%)
At close: Jan 15, 2025, 10:34 AM

Atea Pharmaceuticals Inc. Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for AVIR stock have an median target of 6.88, with a low estimate of 6.88 and a high estimate of 6.88. The median target predicts an increase of 112.35% from the current stock price of 3.24.

Analyst Consensus: Hold
Target Low Average Median High
Price $6.88 $6.88 $6.88 $6.88
Change 112.35% 112.35% 112.35% 112.35%

AI Analyst Report

According to 1 stock analyst, the rating for Atea Pharmaceuticals Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.

Rating Aug 24
Strong Buy 0
Buy 0
Hold 1
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
68.29M
from 0
Increased by -%
Revenue Next Year
7.08M
from 68.29M
Increased by -89.6%
EPS This Year
-1.81
from -1.63
Increased by -11%
EPS Next Year
-1.58
from -1.81
Increased by 12.7%